Our Advisors

Our Advisors are a group of global experts working in a variety of disciplines relevant to the Longitude Prize challenge. They help advise the Longitude Prize team on the development and delivery of the prize.

  • Dr Andrew Bastawrous

    Ophthalmologist (Eye Surgeon) and Clinical Lecturer in International Eye Health at the London School of Hygiene & Tropical Medicine

    Andrew Bastawrous is an Ophthalmologist (Eye Surgeon) and Clinical Lecturer in International Eye Health based at the International Centre for Eye Health, London School of Hygiene & Tropical Medicine. Andrew has worked and undertaken research in Sierra Leone, Peru, Belize, Sri Lanka, Madagascar, Uganda and has recently returned from living in Kenya where he was leading a major eye disease study and the development and testing of Peek, the Portable Eye Examination Kit, a new smartphone based tool to detect eye diseases in the world's most challenging areas. 

  • Entrepreneur

    Naveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is a founder of Moon Express, World Innovation Institute, iNome, TalentWise, Intelius, and Infospace. He is a regular contributor to the Forbes, WSJ, INC and Huffington Post.

  • James King

    Director, Science Practice

    James is a designer who has worked extensively with researchers in biomedical research and healthcare. James’ work has been exhibited internationally and has been added to the permanent collection at MoMA. In 2010, James founded Science Practice – a research and design company in London that collaborates with scientists to put their research into practice and worked with Nesta as lead research partner for Longitude Prize.

  • Prof Ramanan Laxminarayan

    Director and Senior Fellow, Center for Disease Dynamics, Economics & Policy

    Ramanan Laxminarayan

    Ramanan Laxminarayan is director and senior fellow at the Center for Disease Dynamics, Economics & Policy and senior research scholar and lecturer at Princeton University. Through the Extending the Cure Project and the Global Antibiotic Resistance Partnership, he works to improve the understanding of drug resistance as a shared global resource. He is a series editor of the Disease Control Priorities in Developing Countries, 3rd edition.

  • Prof Cliodna McNulty

    Head of Primary Care Unit at Gloucester Public Health England

    Professor Cliodna McNulty is a clinical microbiologist and leads the Gloucester Public Health England Primary Care Unit. The Unit aims to improve community infection management through research, guidance development and public education. Cliodna leads the e-Bug project which provides fun resources and games for young people about microbes, infection and antibiotics. She leads the national antibiotic guidance and diagnostic guides for primary care, and the national TARGET antibiotics toolkit for general practitioners.

  • Dr Pieter Moons

    Lab of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp

    Pieter Moons is a bio-engineer with a background in microbiology and biotechnology. He manages large collaborative projects on diagnostics for infectious diseases involving both academia and industry. Examples include the IMI-funded project RAPP-ID (Development of RApid Point-of-Care test Platforms for Infectious Diseases) and H2020 project ND4ID (New Diagnostics for Infectious Diseases, Marie Curie International Training Network)

  • Dr Jonathan Pearce

    Head of Infection and Immunity, Medical Research Council

    Jonathan Pearce joined the MRC in 2008. Prior to this Jonathan undertook academic research at Cambridge, Oxford and Toronto, followed by roles in life sciences venture capital and strategic consulting. Jonathan is Head of Theme for Infections and Immunity, has managed the Council's £60 million stratified medicine initiative and established the Council's translational research funding scheme, the DPFS.

  • Dr Adam Roberts

    Adam Roberts is a Senior Lecturer at UCL. His group is investigating transferable antimicrobial resistance and microbial pathogenicity, and is also searching for novel antimicrobial molecules produced by bacteria from a wide range of different environments.

  • Dr Craig Rubens

    co-founder and Executive Director, Global Alliance to Prevent Prematurity and Stillbirth

    Craig E. Rubens, MD, PhD, is co-founder and Executive Director of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS). Dr. Rubens is a Professor in the Department of Global Health, and Professor of Pediatrics at University of Washington School of Medicine. He is a member of several prestigious societies, including the American Society of Clinical Investigators and the American Pediatric Society. Dr. Rubens is a physician-scientist and Pediatric Infectious Disease specialist with a strong background in infectious diseases and microbiology.

  • Dr Joanna Stuart OBE

    Director of Development, Northern Ireland Science Park

    Joanne Stuart has over 25 years’ experience working in the IT industry including nine years with the Oracle Corporation. She is responsible for the development of strategic relationships to support the growth of the NI Science Park and the Knowledge Economy in Northern Ireland. At the request of the Ministers for Education and Employment and Learning, Joanne took on the role of Northern Ireland Champion of Science, Technology, Engineering and Mathematics (STEM) to oversee the implementation ‘Success through STEM’ government strategy.

  • Dr Taslimarif Saiyed

    Dr. Taslimarif Saiyed is the Director and COO at the Centre for Cellular and Molecular Platforms (C-CAMP), a Dept. of Biotechnology, Govt. of India initiative, in Bangalore, India. Dr. Saiyed’s initial training has been in neuroscience where he received his PhD from Max-Planck Institute for Brain Research, Germany, and followed by postdoctoral training at University of California San Francisco.

  • Prof Neil Woodford

    Head of the PHE Antimicrobial Resistance and Healthcare Associated Infections Reference Unit (AMRHAI), Public Health England

    Professor Neil Woodford is Head of the Antimicrobial Resistance and Healthcare-Associated Infections (AMRHAI) Reference Unit at Public Health England. A Visiting or Honorary Professor at several universities in the UK and overseas, Neil has worked on antimicrobial resistance for three decades and has co-authored over 300 publications. He sits on many national and international working groups, including the independent Review on AMR.

  • Dr Tachi Yamada

    Venture Partner, Frazier Healthcare

    Dr. Tadataka (Tachi) Yamada is a Venture Partner with Frazier Healthcare.  Prior to that, he was Executive Vice-President, Chief Medical & Scientific Officer and a Board Member of Takeda Pharmaceuticals.  Dr. Yamada has served as President of the Bill & Melinda Gates Foundation Global Health Program. He has received an honorary appointment as Knight Commander of the Most Excellent Order of the British Empire (KBE). He is currently Vice Chair of the Council of the National Academy of Medicine and serves on the Board of Directors of the Clinton Health Access Initiative.